Resting-state alterations in behavioral variant frontotemporal dementia are related to the distribution of monoamine and GABA neurotransmitter systems
Figures

Voxel-wise results for fractional amplitude of low-frequency fluctuation (fALFF) and gray matter volume (GMV) group comparisons.
Thresholded fALFF t-map (A) and thresholded GMV t-map (B) for healthy control (HC; N = 22) > behavioral variant frontotemporal dementia (bvFTD; N = 52) using a permutation-based threshold (1000 permutations permuting group labels) at cluster-level p < 0.05 and voxel-level p < 0.001.

Detailed voxel-wise results for fractional amplitude of low-frequency fluctuation (fALFF) and gray matter volume (GMV) group comparisons.
Thresholded fALFF t-map (A) and thresholded GMV t-map (B) for healthy control (HC; N = 22) > behavioral variant frontotemporal dementia (bvFTD; N = 52) using a permutation-based threshold (1000 permutations permuting group labels) at cluster-level p < 0.05 and voxel-level p < 0.001.

Eigenvariates from fractional amplitude of low-frequency fluctuation (fALFF) and gray matter volume (GMV) for behavioral variant frontotemporal dementia (bvFTD) patients and controls.
Eigenvariates were derived from the largest cluster in the healthy control (HC; N = 22) > behavioral variant frontotemporal dementia (bvFTD; N = 52) contrasts for fALFF (A) and GMV (B). Means are represented by white circles.
-
Figure 1—figure supplement 2—source data 1
Eigenvariates of fractional amplitude of low-frequency fluctuation (fALFF) and gray matter volume (GMV) for largest clusters of healthy control (HC) > behavioral variant frontotemporal dementia (bvFTD) t-contrasts shown in Figure 1—figure supplement 2.
- https://cdn.elifesciences.org/articles/86085/elife-86085-fig1-figsupp2-data1-v1.xlsx

Results of spatial correlation analyses with in vivo and mRNA data.
Correlation of fractional amplitude of low-frequency fluctuation (fALFF) (A) and gray matter volume (GMV) (B) with spatial distribution of neurotransmitter systems incl. 95% confidence intervals. Correlations of Verbal Fluency (N = 49) (C) and Mini Mental State Exam (N = 50) (D) with fALFF–neurotransmitter strength of association incl. bootstrapped 95% confidence intervals. Correlations of fALFF with mRNA gene expression maps (N = 52) (E). Statistically significant correlations in (A), (B), and (E) are marked in red and means are represented by white circles. Black circles in (A), (B), and (E) represent individual Fisher’s z-transformed Spearman correlation coefficients for each patient (N = 52) relative to controls with each neurotransmitter map. Colored circles in (C) and (D) represent individual Fisher’s z-transformed Spearman correlation coefficients between fALFF–neurotransmitter correlations and each neuropsychological scale. The statistical significance of all correlation coefficients was evaluated at p < 0.05 including FDR correction for (A), (B), and (E).
-
Figure 2—source data 1
Fisher’s z-transformed Spearman correlation coefficients shown in Figure 2A–E.
- https://cdn.elifesciences.org/articles/86085/elife-86085-fig2-data1-v1.xlsx

Results of spatial correlation of fractional amplitude of low-frequency fluctuation (fALFF) with mRNA gene expression maps of all γ-aminobutyric acid type A (GABAa) subunits.
Spearman correlation coefficients of mRNA gene expression maps with fALFF for all GABAa subunits (N = 52) (A) and their corresponding correlation matrix (B).
-
Figure 2—figure supplement 1—source data 1
Fisher’s z-transformed Spearman correlation coefficients of fractional amplitude of low-frequency fluctuation (fALFF) with mRNA gene expression of all γ-aminobutyric acid type A (GABAa) subunits shown in Figure 2—figure supplement 1.
- https://cdn.elifesciences.org/articles/86085/elife-86085-fig2-figsupp1-data1-v1.xlsx

Results for fractional amplitude of low-frequency fluctuation (fALFF)–neurotransmitter receiver operating characteristic (ROC) curve, correlations of fALFF–neurotransmitter and gray matter volume (GMV)–neurotransmitter correlations, correlations of neurotransmitter and mRNA gene expression maps, and autocorrelations of mRNA gene expression maps.
ROC curves for healthy controls (HC) vs. behavioral variant frontotemporal dementia (bvFTD) patients are displayed for significant fALFF–neurotransmitter correlations (NbvFTD = 52, NHC = 22) (A). Spearman correlation coefficients of fALFF–neurotransmitter and GMV–neurotransmitter correlations are displayed for each patient and each significant neurotransmitter (N = 52) (B). Spearman correlation coefficients of neurotransmitter and mRNA gene expression maps (C) and autocorrelations of mRNA gene expression maps averaged across mRNA donors (N = 6) (D) are displayed for significant fALFF–neurotransmitter associations incl. 95% confidence intervals.
-
Figure 3—source data 1
Sensitivity and 1 − specificity shown in Figure 3A, fractional amplitude of low-frequency fluctuation (fALFF)–neurotransmitter and gray matter volume (GMV)–neurotransmitter Fisher’s z-transformed Spearman correlation coefficients shown in Figure 3B, and Fisher’s z-transformed Spearman correlation coefficients of neurotransmitter and mRNA gene expression maps shown in Figure 3C ,D.
- https://cdn.elifesciences.org/articles/86085/elife-86085-fig3-data1-v1.xlsx

Results for correlations of neurotransmitter and mRNA gene expression mapsof all γ-aminobutyric acid type A (GABAa) subunits.
Spearman correlation coefficients of mRNA gene expression maps with the GABAa neurotransmitter map (N = 6) (A) and their mRNA autocorrelations (N = 6) (B). The genes encoding the 19 GABAa subunits include GABRA1–6, GABRB1–3, GABRG1–3, GABRR1–3, GABRD, GABRE, GABRP, and GABRQ. Means are represented by white circles.
-
Figure 3—figure supplement 1—source data 1
Fisher’s z-transformed Spearman correlation coefficients of neurotransmitter and mRNA gene expression maps for all γ-aminobutyric acid type A (GABAa) subunits shown in Figure 3—figure supplement 1.
- https://cdn.elifesciences.org/articles/86085/elife-86085-fig3-figsupp1-data1-v1.xlsx
Tables
Demographic and clinical information for bvFTD patients and HC.
bvFTD | HC | Group comparison | ||||
---|---|---|---|---|---|---|
Age (years) | 61.5 ± 10.0 | N = 52 | 63.6 ± 11.9 | N = 22 | t = −0.78 | p = 0.44 |
Sex (male/female) | 38/14 | N = 52 | 9/13 | N = 22 | Χ² = 6.90 | p = 0.009* |
Education (years) | 13.7 ± 3.19 | N = 50 | 13.5 ± 2.56 | N = 22 | t = 0.21 | p = 0.84 |
Disease duration (years) | 3.98 ± 5.22 | N = 49 | – | – | – | – |
Verbal Fluency (number of animals) | 12.2 ± 6.48 | N = 49 | 27.5 ± 4.77 | N = 19 | t = −9.30 | p < 0.001* |
Boston Naming Test (total score) | 12.9 ± 2.79 | N = 49 | 15.0 ± 0.22 | N = 20 | t = −3.28 | p = 0.002* |
Mini Mental State Exam (total score) | 25.2 ± 4.48 | N = 50 | 29.3 ± 0.64 | N = 20 | t = −4.03 | p < 0.001* |
Trail Making Test B (s) | 179 ± 84.4 | N = 36 | 78.5 ± 22.0 | N = 19 | t = 5.09 | p < 0.001* |
Apathy Evaluation Scale (total score) | 32.7 ± 11.0 | N = 35 | 9.50 ± 5.26 | N = 4 | t = 4.13 | p < 0.001* |
Frontal Systems Behavior Scale (companion-rated, total frequency) | 72.7 ± 16.1 | N = 34 | 38.8 ± 12.3 | N = 5 | t = 4.49 | p < 0.001* |
Frontal Systems Behavior Scale (companion-rated, total distress) | 66.9 ± 21.0 | N = 29 | 32 ± 9.56 | N = 4 | t = 3.25 | p = 0.003* |
Frontal Systems Behavior Scale: Executive Function (companion-rated, total distress) | 23.6 ± 7.39 | N = 34 | 11.8 ± 4.50 | N = 4 | t = 3.11 | p = 0.004* |
Clinical Dementia Rating-Frontotemporal Lobar Degeneration (total score) | 8.06 ± 3.92 | N = 45 | 0.05 ± 0.16 | N = 19 | t = 5.07 | p < 0.001* |
-
bvFTD – behavioral variant frontotemporal dementia, HC – healthy controls.
-
*
Significant at p < 0.05.
Center-specific imaging parameters for structural and functional imaging.
Center | rsfMRI | Structural MRI | |||||||
---|---|---|---|---|---|---|---|---|---|
TE (ms) | TR (ms) | FOV(X, Y, Z) | Voxel size (mm) | Volumes | TE (ms) | TR (ms) | FOV(X, Y, Z) | Voxel size (mm) | |
Bonn | 30 | 2000 | 64 × 64 × 30 | 3 × 3 × 5 | 300 | 3.06 | 2300 | 240 × 256 × 176 | 1 × 1 × 1 |
Erlangen | 34 | 3000 | 64 × 64 × 30 | 3 × 3 × 5 | 300 | 2.98 | 2300 | 240 × 256 × 176 | 1 × 1 × 1 |
Göttingen | 30 | 2000 | 64 × 64 × 30 | 3 × 3 × 6 | 300 | 2.96 | 2300 | 256 × 256 × 176 | 1 × 1 × 1 |
Homburg | 30 | 2000 | 64 × 64 × 30 | 3 × 3 × 5 | 300 | 2.98 | 2300 | 240 × 256 × 176 | 1 × 1 × 1 |
Leipzig | 30 | 2000 | 64 × 64 × 30 | 3 × 3 × 5 | 300 | 2.98 | 2300 | 240 × 256 × 176 | 1 × 1 × 1 |
München (TU) | 30 | 2000 | 64 × 64 × 30 | 3 x 3 × 5 | 300 | 2.98 | 2300 | 240 × 256 × 176 | 1 × 1 × 1 |
Rostock | 30 | 2200 | 64 × 64 × 34 | 3.5 × 3.5 × 3.5 | 300 | 4.82 | 2500 | 256 × 256 × 192 | 1 × 1 × 1 |
Tübingen | 30 | 2000 | 64 × 64 × 30 | 3 × 3 × 5 | 300 | 2.96 | 2300 | 240 × 256 × 176 | 1 × 1 × 1 |
Ulm | 30 | 2000 | 64 × 64 × 30 | 3 × 3 × 5 | 300 | 2.05 | 2300 | 240 × 256 × 192 | 1 × 1 × 1 |
-
rsfMRI – resting-state functional magnetic resonance imaging, MRI – magnetic resonance imaging, TE – echo time, TR – repetition time, FOV – field of view.
-
Bonn – University of Bonn, German Center for Neurodegenerative Diseases (DZNE), University Hospital Bonn.
-
Erlangen – University Hospital Erlangen.
-
Göttingen – Medical University Göttingen.
-
Homburg – Saarland University Hospital.
-
Leipzig – Max-Planck-Institute for Human Cognitive and Brain Sciences.
-
TU München – Technical University of Munich.
-
Rostock – University Hospital Rostock, German Center for Neurodegenerative Diseases (DZNE).
-
Tübingen – University Hospital Tübingen, Centre for Neurology, Hertie-Institute for Clinical Brain Research.
-
Ulm – Ulm University.
Additional files
-
Supplementary file 1
Supplementary tables including information about the subject distribution across centers, detailed information about the neurotransmitter maps, contrast peak voxel information for the t-contrasts, Spearman correlation coefficients and corresponding p-values from the fALFF- and GMV-neurotransmitter analyses and their relationship to clinical symptoms.
- https://cdn.elifesciences.org/articles/86085/elife-86085-supp1-v1.docx
-
MDAR checklist
- https://cdn.elifesciences.org/articles/86085/elife-86085-mdarchecklist1-v1.pdf